ASH Research Collaborative
Accelerating Progress in Hematology
The National Community Advisory Board (CAB) Working Group, a working group of the Patient Engagement and Education Subcommittee, is tasked with:
The National CAB Working Group consists of two members (one primary and one alternate) from each local CAB of each Clinical Trials Unit (CTU) in the Sickle Cell Disease Clinical Trials Network. The national CAB shall select a chair and vice chair to lead the National CAB Working Group.
The National CAB Working Group meets at least once annually, either in-person or virtually if necessary.